pharmaceuticals-and-healthcare

United States Immuno-oncology Drugs Market Report 2018


Published On : Jul 2018

Category : Pharmaceutical

No. of Pages : 115 pages

  • $3800
  • $7600

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
In this report, the United States Immuno-oncology Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Immuno-oncology Drugs in these regions, from 2013 to 2025 (forecast).

United States Immuno-oncology Drugs market competition by top manufacturers/players, with Immuno-oncology Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Pharmacies
Online Pharmacies

In the recent times, the global market for United states immuno oncology drugs market report 2018 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states immuno oncology drugs market report 2018 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states immuno oncology drugs market report 2018 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states immuno oncology drugs market report 2018 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states immuno oncology drugs market report 2018 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states immuno oncology drugs market report 2018, including the definition, classification, and industry chain structure of United states immuno oncology drugs market report 2018, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states immuno oncology drugs market report 2018.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states immuno oncology drugs market report 2018 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states immuno oncology drugs market report 2018, implemented in each of the geographical segments. The predominant applications of the United states immuno oncology drugs market report 2018 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states immuno oncology drugs market report 2018 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states immuno oncology drugs market report 2018 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Immuno-oncology Drugs
Figure United States Immuno-oncology Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Immuno-oncology Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Immune Checkpoint Inhibitors Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Cytokine-Based Immunotherapy Product Picture
Figure Cancer Vaccines Product Picture
Figure CAR-T Cell Therapy Product Picture
Figure United States Immuno-oncology Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Immuno-oncology Drugs by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure United States Immuno-oncology Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Immuno-oncology Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Immuno-oncology Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Immuno-oncology Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immuno-oncology Drugs Sales Share by Players/Suppliers
Figure 2017 United States Immuno-oncology Drugs Sales Share by Players/Suppliers
Figure United States Immuno-oncology Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Immuno-oncology Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Immuno-oncology Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Immuno-oncology Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Immuno-oncology Drugs Revenue Share by Players/Suppliers
Table United States Market Immuno-oncology Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Immuno-oncology Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Immuno-oncology Drugs Market Share of Top 3 Players/Suppliers
Figure United States Immuno-oncology Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immuno-oncology Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immuno-oncology Drugs Product Category
Table United States Immuno-oncology Drugs Sales (K Units) by Region (2013-2018)
Table United States Immuno-oncology Drugs Sales Share by Region (2013-2018)
Figure United States Immuno-oncology Drugs Sales Share by Region (2013-2018)
Figure United States Immuno-oncology Drugs Sales Market Share by Region in 2017
Table United States Immuno-oncology Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Immuno-oncology Drugs Revenue Share by Region (2013-2018)
Figure United States Immuno-oncology Drugs Revenue Market Share by Region (2013-2018)
Figure United States Immuno-oncology Drugs Revenue Market Share by Region in 2017
Table United States Immuno-oncology Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Immuno-oncology Drugs Sales (K Units) by Type (2013-2018)
Table United States Immuno-oncology Drugs Sales Share by Type (2013-2018)
Figure United States Immuno-oncology Drugs Sales Share by Type (2013-2018)
Figure United States Immuno-oncology Drugs Sales Market Share by Type in 2017
Table United States Immuno-oncology Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immuno-oncology Drugs by Type (2013-2018)
Figure Revenue Market Share of Immuno-oncology Drugs by Type in 2017
Table United States Immuno-oncology Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Immuno-oncology Drugs Sales Growth Rate by Type (2013-2018)
Table United States Immuno-oncology Drugs Sales (K Units) by Application (2013-2018)
Table United States Immuno-oncology Drugs Sales Market Share by Application (2013-2018)
Figure United States Immuno-oncology Drugs Sales Market Share by Application (2013-2018)
Figure United States Immuno-oncology Drugs Sales Market Share by Application in 2017
Table United States Immuno-oncology Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Immuno-oncology Drugs Sales Growth Rate by Application (2013-2018)
Table Amgen, Inc Basic Information List
Table Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table AstraZeneca, Plc Basic Information List
Table AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Hoffmann-La Roche AG Basic Information List
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Novartis International AG Basic Information List
Table Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table AbbVie, Inc. Basic Information List
Table AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Sales Market Share in United States (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Revenue Market Share in United States (2013-2018)
Table Pfizer Inc. Basic Information List
Table Sanofi S.A. Basic Information List
Table EMD Serono, Inc. Basic Information List
Table Gilead Sciences Inc. Basic Information List
Table Prometheus Therapeutics & Diagnostics Basic Information List
Table Aduro BioTech Basic Information List
Table Galena Biopharma Basic Information List
Table Bavarian Nordic Basic Information List
Table Celldex Therapeutics Basic Information List
Table ImmunoCellular Therapeutics Basic Information List
Table Incyte Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immuno-oncology Drugs
Figure Manufacturing Process Analysis of Immuno-oncology Drugs
Figure Immuno-oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immuno-oncology Drugs Major Players/Suppliers in 2017
Table Major Buyers of Immuno-oncology Drugs
Table Distributors/Traders List
Figure United States Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Immuno-oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Immuno-oncology Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Immuno-oncology Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Immuno-oncology Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Immuno-oncology Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Immuno-oncology Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Immuno-oncology Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Immuno-oncology Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Immuno-oncology Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Immuno-oncology Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immuno-oncology Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Immuno-oncology Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top